Novel first-in-class therapeutic targeting a key immune signaling pathway and the underlying cause of HITIt is the first and only potent, highly selective inhibitor of human 12-LOX in clinical testing ...

Data demonstrate superior efficacy compared to ruxolitinib, an approved type I JAK2 inhibitor, including reductions in mutant ...

CBSE Class 12 Board Exams 2026 are approaching, and Mathematics continues to be a crucial subject for students in the Science ...

Hundreds of police officers were searching for the gunman after he escaped into the streets of Rhode Island’s capital, ...

Discover why Structure Therapeutics Inc. is rated Strong Buy after positive Aleniglipron phase 2b obesity data. Click for ...

Greatland Resources' feasibility study for its Havieron gold-copper project in WA confirms the asset as a world-class, ...

Some patients dropped out of the trial early because they had lost so much weight.

With less than 150 days left for the board exams, students are advised to start solving PYQs and sample papers. Here's a ...

Major histocompatibility complex class II (MHC-II) molecules play a critical, yet historically overlooked, role in tumor ...

New research suggests that drugs like Ozempic and Wegovy might trigger more than just a slimmer waistline. Many users have reported digestive issues while taking the medications, including nausea, ...

A Utah social studies teacher's social media side project HAS became a full-blown platform — but he still says he's a teacher first ...

PR Newswire Antengene Announces IND Approval in China for Phase Ib/II Study of ATG-022 (CLDN18.2 ADC) in Combination with KEYTRUDA® (Pembrolizumab) ± Chemotherapy ...